PDCD1 and melanoma: Primary tumor histology also has an influence that distinct tumor types have histologically specific irAE patterns when treated with PD-1 suppressors, perhaps attributed to diverse TMEs and immune infiltration (81), with research identifying a higher risk of small bowel colitis in melanoma compared with NSCLC and renal cell carcinoma (95).